AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2020
May 4, 2020
35599_dirs_2020-05-04_a945a6cd-686e-49b1-a171-53b3a8934c6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2020-04-30
Reporting Person: Essetifin SPA (10% Owner)
Reporting Person: CAVAZZA PAOLO (10% Owner)
Reporting Person: Cavazza Enrico (10% Owner)
Reporting Person: Cavazza Francesca (10% Owner)
Reporting Person: Cavazza Silvia (10% Owner)
Reporting Person: Cavazza Preta Martina (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-30 | Common Stock | P | 768000 | $6.25 | Acquired | 3993694 | Direct |
Footnotes
F1: Such shares were purchased in connection with an underwritten public offering by the issuer, which closed on May 4, 2020.
F2: Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.